Tempus AI built the world's largest library of clinical and molecular data β 7 million+ patient records with integrated genomic sequencing β to train AI models that match cancer patients to clinical trials, predict treatment response, and identify novel biomarkers. Its TIME trial matching platform connected 1 in 5 eligible cancer patients to relevant clinical trials, addressing the longstanding problem that 85% of trials fail due to insufficient enrollment.

Comments on "Tempus AI Cancer Genomics"
Create a free account or sign in to join the discussion.
Sign in to join the conversation